TABLE I.
Generations | n | Body (g) | Ventral prostate (g) | Ventral prostate/body ratio | Testosterone (ng/mL) |
---|---|---|---|---|---|
A: Young adult rats (P70–P120) | |||||
F1 Control | 9 | 513 ± 12.6 | 0.97 ± 0.07 | 1.70 ± 0.11 | 3.93 ± 0.39 |
F1 Vinclozolin | 9 | 517 ± 12.0 | 0.81 ± 0.09 | 1.57 ± 0.17 | 4.57 ± 0.40 |
F2 Control | 10 | 415 ± 25.1 | 0.59 ± 0.06 | 1.41 ±.10 | 5.35 ± 1.14 |
F2 Vinclozolin | 10 | 414 ± 27.4 | 0.71 ± 0.08 | 1.67 ± 0.11 | 4.78 ± 1.14 |
F3 Control | 8 | 551 ± 14.9 | 1.08 ± 0.08 | 1.95 ± 0.11 | 3.65 ± 0.42 |
F3 Vinclozolin | 14 | 537 ± 15.8 | 1.21 ± 0.07 | 2.56 ± 0.11 | 3.62 ± 0.30 |
B: Aged adult rats (P180–P420) | |||||
F1 Control | 6 | 676 ± 26.0 | 1.19 ± 0.05 | 1.77 ± 0.05 | 1.86 ± 0.45 |
F1 Vinclozolin | 8 | 635 ± 17.3 | 1.39 ± 0.09 | 2.20 ± 0.14 | 1.76 ± 0.24 |
F2 Control | 21 | 592 ± 18.2 | 1.08 ± 0.05 | 1.86 ± 0.09 | 1.02 ± 0.07 |
F2 Vinclozolin | 23 | 711 ± 21.1* | 1.43 ± 0.08* | 2.03 ± 0.11 | 1.15 ± 0.12 |
F3 Control | 5 | 518 ± 21.1 | 1.11 ± 0.08 | 2.15 ± 0.17 | 1.21 ± 0.20 |
F3 Vinclozolin | 12 | 613 ± 28.0* | 0.89 ± 0.06* | 1.47 ± 0.09* | 0.88 ± 0.12 |
F4 Control | 13 | 607 ± 27.2 | 1.58 ± 0.08 | 2.60 ± 0.16 | 1.77 ± 0.30 |
F4 Vinclozolin | 8 | 622 ± 24.6 | 1.75 ± 0.10 | 2.84 ± 0.18 | 1.64 ± 0.20 |
VOC | 19 | 629 ± 25.7 | 1.32 ± 0.10 | 2.07 ± 0.04 | 0.88 ± 0.09** |
RVOC | 5 | 699 ± 6.96 | 1.55 ± 0.02 | 2.22 ± 0.04 | 1.77 ± 0.26 |
P >0.05 from corresponding control value.
P >0.05 from corresponding RVOC value.